The McGill RAAS-COVID-19 Trial

NCT04508985 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Cardiovascular Diseases

Interventions

OTHER: Temporarily holding the RAAS inhibitor [intervention]
OTHER: RAAS inhibitor [continued standard of care]

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators

[object Object]
[object Object]
[object Object]